Double-blind, randomized, placebo-controlled trial showing ‘remdesivir shortens #COVID19 time to recovery’, @NEJM https://tinyurl.com/ybgnd3dh . Remdesivir seems not good in severe #COVID19, but in those cases convalescent plasma increases survival: https://tinyurl.com/yce9emoy .pic.twitter.com/Ov11BH1umd

Double-blind, randomized, placebo-controlled trial showing ‘remdesivir shortens time to recovery’, https://tinyurl.com/ybgnd3dh . Remdesivir seems not good in severe , but in those cases convalescent plasma increases survival: https://tinyurl.com/yce9emoy .

Go to Source
Author: (@ACabezasCruz)



The International Natural Product Sciences Taskforce (INPST) maintains up-to-date lists with conferencesgrants and funding opportunitiesjobs and open positions, and journal special issues with relevance for the area of phytochemistry and food chemistry, pharmacology, biotechnology, medicine and pharmacognosy research, and natural product science.

Join for free INPST as a member

INPST social media channels



0 0 vote
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments